BDTX vs NKE · $95.7M cap vs P/E 35, rev $46.31B
Black Diamond Therapeutics Inc (BDTX) versus Nike Inc (NKE) — a side-by-side from cached financials, not a winner call.
Black Diamond Therapeutics Inc (BDTX) is a biotechnology company listed on NASDAQ.
Nike Inc (NKE) is a footwear & accessories company listed on US. It is led by John Donahoe.
BDTX does not have a complete income-statement cache yet.
Latest reported NKE revenue for 2025-05-31 was $46.31B. Net income was $3.22B. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
BDTX currently screens at market cap $95.7M. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
Not investment advice. Open the BDTX and NKE stock pages for the full models.
Not investment advice.